世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Cervical Cancer Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
Global Cervical Cancer Market, Analysis and Forecast: 2025-2035 Cervical cancer is a malignant tumor arising from the cervix, the lower, narrow end of the uterus that connects to the vagina. It ... もっと見る
英語原文をAIを使って翻訳しています。
SummaryGlobal Cervical Cancer Market, Analysis and Forecast: 2025-2035Cervical cancer is a malignant tumor arising from the cervix, the lower, narrow end of the uterus that connects to the vagina. It is primarily caused by persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus. The disease progresses through precancerous lesions (cervical intraepithelial neoplasia) before developing into invasive cancer, primarily squamous cell carcinoma or adenocarcinoma. The increasing burden of cervical cancer is one of the major factors driving the market growth. Cervical cancer ranks as the fourth most prevalent cancer among women worldwide, with the World Health Organization (WHO) reporting approximately 604,000 new cases and 342,000 deaths in 2020. The disease disproportionately affects low- and middle-income countries (LMICs), which bear nearly 90% of cervical cancer-related mortality, largely due to inadequate screening programs and limited access to HPV vaccination. Globally, persistent infection with high-risk human papillomavirus (HPV) types 16 and 18 is responsible for about 70% of cervical cancer cases. The approval and increasing use of immune checkpoint inhibitors, have revolutionized the treatment landscape for recurrent or metastatic cervical cancer. These therapies offer improved survival benefits and are driving significant market growth by providing alternatives to traditional chemotherapy, particularly in advanced disease stages. Moreover, the expansion of HPV vaccination programs will reduce future treatment burden. While HPV vaccines are preventive, their increasing global adoption directly impacts the therapeutic market by reducing the incidence of cervical cancer over time. This has encouraged pharmaceutical companies to invest in comprehensive cervical cancer portfolios spanning prevention, diagnostics, and treatment. For instance, global vaccination campaigns have accelerated HPV vaccine uptake in LMICs, influencing long-term drug market dynamics by shifting focus toward advanced-stage therapies and precision medicine. However, the high cost of novel immunotherapies and targeted agents limits their accessibility, particularly in LMICs where the disease burden is highest. Reimbursement challenges, lack of healthcare infrastructure, and patient affordability constrain widespread adoption. In addition, cervical cancer’s molecular heterogeneity and evolving resistance mechanisms to therapies like chemotherapy and immunotherapy pose ongoing challenges. This necessitates continuous drug development and combination strategies to enhance efficacy and overcome resistance. Pharmaceutical companies are actively exploring combinations of immunotherapies with chemotherapy, targeted agents, and radiotherapy to improve clinical outcomes and extend progression-free survival. These regimens represent a growing segment in clinical development pipelines. Moreover, advances in molecular diagnostics are enabling biomarker-guided therapies, improving patient selection for treatments such as PD-L1 inhibitors and enhancing response rates, thus driving the market toward precision oncology. The cervical cancer market is highly competitive, dominated by major pharmaceutical companies with comprehensive portfolios spanning immunotherapies, targeted treatments, and preventive vaccines. The competitive environment is further shaped by collaborations between pharmaceutical companies and global health organizations to enhance vaccine coverage and access to therapies in low- and middle-income countries. However, regulatory complexities, pricing pressures, and upcoming patent expirations pose challenges that drive ongoing innovation and strategic market expansion. Companies that excel in integrating innovation, affordability, and global partnerships are best positioned to lead in this evolving cervical cancer market. Table of ContentsExecutive SummaryScope and Definition Market/Product Definition Inclusion and Exclusion Key Questions Answered Analysis and Forecast Note 1. Global Magnetic Resonance Imaging Systems Market: Industry Analysis 1.1 Key Market Trends 1.1.1 Impact Analysis 1.2 Patent Analysis 1.2.1 Patent Filing Trend (by Country) 1.2.2 Patent Filing Trend (by Year) 1.3 Regulatory Landscape 1.4 Installed Base of Magnetic Resonance Imaging Systems, Thousands, 2023-2025 1.5 Market Dynamics 1.5.1 Impact Analysis 1.5.2 Market Drivers 1.5.3 Market Restraints 1.5.4 Market Opportunities 2. Global Magnetic Resonance Imaging Systems Market, by Field Strength, $Million, 2023-2035 2.1 High and Very High Field MRI Systems 2.1.1 1.5 T MRI Systems 2.1.2 3T MRI Systems 2.2 Low and Mid-Field MRI Systems 3. Global Magnetic Resonance Imaging Systems Market, by Architecture, $Million, 2023-2035 3.1 Closed MRI Systems 3.2 Open MRI Systems 4. Global Magnetic Resonance Imaging Systems Market, by Design, $Million, 2023-2035 4.1 Portable 4.2 Fixed/Stationary 5. Global Magnetic Resonance Imaging Systems Market, by Application, $Million, 2023-2035 5.1 Brain and Neurological MRI 5.2 Spine and Musculoskeletal MRI 5.3 Cardiac MRI 5.4 Others 6. Global Magnetic Resonance Imaging Systems Market, by End User, $Million, 2023-2035 6.1 Hospitals 6.2 Diagnostic Imaging Centers 6.3 Others 7. Global Magnetic Resonance Imaging Systems Market, Region, $Million, 2023-2035 7.1 North America Magnetic Resonance Imaging (MRI) Systems Market 7.1.1 Market Dynamics 7.1.2 Market Sizing and Forecast 7.1.2.1 North America Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.1.2.2 North America Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.1.2.3 North America Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.1.2.4 North America Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.1.2.5 North America Magnetic Resonance Imaging Systems Market, by Country ($Million), 2023-2035 7.1.2.5.1 U.S. 7.1.2.5.1.1 U.S. Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.1.2.5.1.2 U.S. Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.1.2.5.1.3 U.S. Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.1.2.5.1.4 U.S. Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.1.2.5.2 Canada 7.1.2.5.2.1 Canada Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.1.2.5.2.2 Canada Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.1.2.5.2.3 Canada Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.1.2.5.2.4 Canada Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2 Europe 7.2.1 Market Dynamics 7.2.2 Market Sizing and Forecast 7.2.2.1 Europe Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.2 Europe Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.3 Europe Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.4 Europe Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5 Europe Magnetic Resonance Imaging Systems Market, by Country ($Million), 2023-2035 7.2.2.5.1 U.K. 7.2.2.5.1.1 U.K. Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.1.2 U.K. Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.1.3 U.K. Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.1.4 U.K. Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5.2 France 7.2.2.5.2.1 France Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.2.2 France Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.2.3 France Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.2.4 France Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5.3 Germany 7.2.2.5.3.1 Germany Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.3.2 Germany Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.3.3 Germany Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.3.4 Germany Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5.4 Italy 7.2.2.5.4.1 Italy Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.4.2 Italy Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.4.3 Italy Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.4.4 Italy Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5.5 Spain 7.2.2.5.5.1 Spain Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.5.2 Spain Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.5.3 Spain Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.5.4 Spain Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.2.2.5.6 Rest-of-Europe 7.2.2.5.6.1 Rest-of-Europe Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.2.2.5.6.2 Rest-of-Europe Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.2.2.5.6.3 Rest-of-Europe Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.2.2.5.6.4 Rest-of-Europe Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3 Asia-Pacific 7.3.1 Market Dynamics 7.3.2 Market Sizing and Forecast 7.3.2.1 Asia-Pacific Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.2 Asia-Pacific Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.3 Asia-Pacific Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.4 Asia-Pacific Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5 Asia-Pacific Magnetic Resonance Imaging Systems Market, by Country ($Million), 2023-2035 7.3.2.5.1 Japan 7.3.2.5.1.1 Japan Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.1.2 Japan Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.1.3 Japan Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.1.4 Japan Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5.2 China 7.3.2.5.2.1 China Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.2.2 China Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.2.3 China Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.2.4 China Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5.3 India 7.3.2.5.3.1 India Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.3.2 India Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.3.3 India Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.3.4 India Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5.4 Australia 7.3.2.5.4.1 Australia Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.4.2 Australia Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.4.3 Australia Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.4.4 Australia Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5.5 South Korea 7.3.2.5.5.1 South Korea Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.5.2 South Korea Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.5.3 South Korea Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.5.4 South Korea Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.3.2.5.6 Rest-of-Asia-Pacific 7.3.2.5.6.1 Rest-of-Asia-Pacific Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.3.2.5.6.2 Rest-of-Asia-Pacific Magnetic Resonance Imaging Systems Market, by Architecture ($Million), 2023-2035 7.3.2.5.6.3 Rest-of-Asia-Pacific Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.3.2.5.6.4 Rest-of-Asia-Pacific Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.3.2.5.6.5 Rest-of-Asia-Pacific Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 7.4 Rest-of-the-World 7.4.1 Market Dynamics 7.4.2 Market Sizing and Forecast 7.4.2.1 Rest-of-the-World Magnetic Resonance Imaging Systems Market, by Field Strength ($Million), 2023-2035 7.4.2.2 Rest-of-the-World Magnetic Resonance Imaging Systems Market, by Architecture ($Million), 2023-2035 7.4.2.3 Rest-of-the-World Magnetic Resonance Imaging Systems Market, by Design ($Million), 2023-2035 7.4.2.4 Rest-of-the-World Magnetic Resonance Imaging Systems Market, by Application ($Million), 2023-2035 7.4.2.5 Rest-of-the-World Magnetic Resonance Imaging Systems Market, by End User ($Million), 2023-2035 8. Global Magnetic Resonance Imaging (MRI) Systems Market, Competitive Landscape and Company Profiles 8.1 Competitive Landscape 8.1.1 Mergers and Acquisitions 8.1.2 Partnership, Alliances, and Business Expansion 8.1.3 New Offerings 8.1.4 Regulatory Activities 8.1.5 Funding Activities 8.2 Company Profiles 8.2.1 GE HealthCare 8.2.1.1 Overview 8.2.1.2 Top Products / Product Portfolio 8.2.1.3 Top Competitors 8.2.1.4 Target Customers/End-Users 8.2.1.5 Key Personnel 8.2.1.6 Analyst View 8.2.2 Siemens Healthineers AG 8.2.2.1 Overview 8.2.2.2 Top Products / Product Portfolio 8.2.2.3 Top Competitors 8.2.2.4 Target Customers/End-Users 8.2.2.5 Key Personnel 8.2.2.6 Analyst View 8.2.3 Koninklijke Philips N.V. 8.2.3.1 Overview 8.2.3.2 Top Products / Product Portfolio 8.2.3.3 Top Competitors 8.2.3.4 Target Customers/End-Users 8.2.3.5 Key Personnel 8.2.3.6 Analyst View 8.2.4 Canon Medical Systems Corporation 8.2.4.1 Overview 8.2.4.2 Top Products / Product Portfolio 8.2.4.3 Top Competitors 8.2.4.4 Target Customers/End-Users 8.2.4.5 Key Personnel 8.2.4.6 Analyst View 8.2.5 Hologic, Inc. 8.2.5.1 Overview 8.2.5.2 Top Products / Product Portfolio 8.2.5.3 Top Competitors 8.2.5.4 Target Customers/End-Users 8.2.5.5 Key Personnel 8.2.5.6 Analyst View 8.2.6 Hitachi Healthcare (Hitachi High-Tech Corporation) 8.2.6.1 Overview 8.2.6.2 Top Products / Product Portfolio 8.2.6.3 Top Competitors 8.2.6.4 Target Customers/End-Users 8.2.6.5 Key Personnel 8.2.6.6 Analyst View 8.2.7 Fujifilm Holdings Corporation 8.2.7.1 Overview 8.2.7.2 Top Products / Product Portfolio 8.2.7.3 Top Competitors 8.2.7.4 Target Customers/End-Users 8.2.7.5 Key Personnel 8.2.7.6 Analyst View 8.2.8 Others 9. Research Methodology List of Tables/GraphsList of FiguresFigure: Magnetic Resonance Imaging Systems Market (by Scenario), $Million, 2024, 2030, and 2035 Figure: Global Magnetic Resonance Imaging Systems Market, 2024 and 2035 Figure: Global Magnetic Resonance Imaging Systems Market Key Trends, Impact Analysis, 2023-2035 Figure: North America Magnetic Resonance Imaging Systems Market, $Million, 2023-2035 Figure: Europe Magnetic Resonance Imaging Systems Market, $Million, 2023-2035 Figure: Asia-Pacific Magnetic Resonance Imaging Systems Market, $Million, 2023-2035 List of Tables Table: Market Snapshot Table: Market Dynamics Table: Global Magnetic Resonance Imaging Systems Market (by Field Strength), $Million, 2023-2035 Table: Global Magnetic Resonance Imaging Systems Market (by Architecture), $Million, 2023-2035 Table: Global Magnetic Resonance Imaging Systems Market (by Design), $Million, 2023-2035 Table: Global Magnetic Resonance Imaging Systems Market (by Application), $Million, 2023-2035 Table: Global Magnetic Resonance Imaging Systems Market (by End User), $Million, 2023-2035 Table: Global Magnetic Resonance Imaging Systems Market (by Region), $Million, 2023-2035
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
BIS Research社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD（cervical cancer）の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
